Skip to main content
Smart Investors Daily
HA

OTC · HAWPY

Haw Par Corporation Limited

Healthcare · Drug Manufacturers - General

$53.50

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 3:08 PM

SID Score

5.7/10

Composite research score

Smart Money

46/100

Neutral

Market cap
2.81B
P/E ratio
13.87
Dividend yield
8.10%
52-week range
— – —
Volume
1
Avg. volume
2

Price performance · HAWPY

HAWPY price history

1M range · 0 trading sessions · Daily adjusted prices

HAWPY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest HAWPY news

The latest Smart Investors Daily articles mentioning HAWPY.

HAWPY research

Overview

Company profile and research snapshot.

Company profile

HAW PAR CORP LTD UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 18, 2026

Is Haw Par (SGX:H02) Fully Priced After A 61% Run?

Haw Par has delivered a strong 60.6% gain over the past 3 years, which naturally raises the question of whether the current share price still lines up with what its earnings can support. With the stock now around $12.94, investors are weighing a solid multi‑year return against more mixed shorter term moves, and asking how much of the business performance is already reflected in the valuation. A 60.6% return over 3 years puts Haw Par in focus for anyone asking whether that kind of share price...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.